Check out our most popular compounded medications! Get Started
Morphine Sulfate 3% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This allows for easy and precise application on the skin, providing targeted treatment for conditions such as chronic pain, neuropathic pain, arthritis, fibromyalgia, and migraines. The gel-like consistency ensures fast-acting relief upon direct application.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Morphine Sulfate 3% Topical Gel is a prescription medication specifically designed to alleviate moderate to severe pain. This semisolid formulation is dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment or absorption of active ingredients. The gel-like consistency allows for a smooth application process.
The active ingredient in this formulation is morphine sulfate, a potent opioid analgesic. It functions by inhibiting pain signals from reaching the brain, thereby providing relief from various types of pain, including post-operative pain, chronic pain, and cancer-related pain.
Using Morphine Sulfate 3% Topical Gel is straightforward. It is applied directly to the area experiencing pain, as per the instructions provided by your healthcare provider. It is crucial to adhere to these instructions and not exceed the recommended dosage to ensure the medication's effectiveness and safety.
While Morphine Sulfate 3% Topical Gel is a appropriate treatment for pain, it is important to be aware of potential side effects. These may include skin irritation, itching, and redness. If you experience any of these side effects, it is recommended to contact your healthcare provider immediately.
If you have any questions about Morphine Sulfate 3% Topical Gel or would like to learn more about how it can help manage your pain, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of experienced compounding pharmacists is here to assist you with your medication needs and provide you with the necessary information to make informed decisions about your health.
Morphine Sulfate 3% Topical Gel is a semisolid formulation that is contraindicated in patients with known hypersensitivity to morphine or any of the components of the formulation. It is dispensed through a pump mechanism, which allows for easy and precise application on the skin for targeted treatment or absorption of active ingredients.
Patients using this formulation should be closely monitored for signs of opioid toxicity, which may include respiratory depression, sedation, and constipation. Special caution should be exercised when using Morphine Sulfate 3% Topical Gel in patients with renal or hepatic impairment, as well as in those with a history of substance abuse.
This formulation should not be used in patients with a history of seizures or in those taking other medications that may increase the risk of seizures. It should also be used with caution in patients with a history of cardiovascular disease, as it may increase the risk of hypotension.
Morphine Sulfate 3% Topical Gel should be used with caution in patients with a history of gastrointestinal obstruction, as it may increase the risk of constipation. It should also be used with caution in patients with a history of depression, as it may increase the risk of suicidal thoughts or behaviors.
Patients with a history of head injury or increased intracranial pressure should use this formulation with caution, as it may increase the risk of respiratory depression. It should also be used with caution in patients with a history of alcohol or drug abuse, as it may increase the risk of addiction.
Morphine Sulfate 3% Topical Gel should be used with caution in patients with a history of asthma, as it may increase the risk of bronchospasm. It is not recommended for use in pregnant or breastfeeding women. If you have any questions regarding this formulation, please reach out to us.
Morphine Sulfate 3% Topical Gel is a semisolid formulation of morphine sulfate, a potent opioid analgesic, dispensed through a pump mechanism. This formulation is designed for easy and precise application on the skin, facilitating targeted treatment or absorption of the active ingredient. It is primarily used to manage moderate to severe pain associated with various disease states, including cancer, post-operative pain, and chronic pain conditions.
The gel is applied directly to the affected area, typically twice a day or as directed by a healthcare professional. It is absorbed through the skin, working by blocking pain signals from reaching the brain, thus providing relief from pain. It is crucial to adhere to the instructions provided by your doctor or pharmacist when using this medication. The gel should be used exactly as prescribed, and the recommended dose should not be exceeded. Care should be taken to avoid contact with the eyes, nose, and mouth.
While Morphine Sulfate 3% Topical Gel is generally well tolerated, side effects may occur. Common side effects include skin irritation, itching, redness, and burning at the application site. If these side effects occur, it is important to contact your healthcare provider. Other potential side effects may include nausea, vomiting, constipation, and drowsiness.
If you have any questions about Morphine Sulfate 3% Topical Gel or its mechanism of action, do not hesitate to reach out to your healthcare provider. They are equipped to provide you with the necessary information and guide you in finding the best treatment for your condition.
Morphine Sulfate 3% Topical Gel is a semisolid formulation of morphine, a powerful pain reliever. It is dispensed through a pump mechanism for easy and precise application on the skin.
The gel is designed to be absorbed through the skin, delivering the active ingredient, morphine sulfate, directly to the targeted area for pain relief.
The gel should be applied to the skin in the area where pain relief is needed. It is dispensed through a pump mechanism, which allows for easy and precise application.
Morphine Sulfate 3% Topical Gel is intended for targeted treatment of specific areas of pain. It is not recommended for widespread or generalized pain. Always consult your healthcare provider before starting any new medication.
As with any medication, Morphine Sulfate 3% Topical Gel can have side effects. These may include skin irritation at the application site. If you experience any unusual symptoms, contact your healthcare provider immediately.
Before using Morphine Sulfate 3% Topical Gel, it is important to discuss with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
Before starting Morphine Sulfate 3% Topical Gel, inform your healthcare provider about all other medications you are currently taking. This includes prescription and over-the-counter medications, vitamins, and herbal supplements.
Morphine Sulfate 3% Topical Gel should be stored at room temperature, away from heat and direct light. Keep the container tightly closed when not in use.
If you miss a dose of Morphine Sulfate 3% Topical Gel, apply it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not apply extra gel to make up for a missed dose.
If you suspect an overdose of Morphine Sulfate 3% Topical Gel, seek emergency medical attention immediately. Symptoms of an overdose may include extreme drowsiness, slow breathing, or loss of consciousness.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
